Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -158.48 | -88.26 |
| PEG Ratio (TTM) | -2.64 | -1.44 |
| P/S Ratio (TTM) | 2.79 | 2.67 |
| P/B Ratio (TTM) | 1.62 | 1.55 |
| P/FCF Ratio (TTM) | 28.69 | -2.90 |
| Price to 5YR AVG Earnings Ratio | -1,407.66 | -15.87 |
| Price to 5YR AVG FCF Ratio | 111.34 | 40.58 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.66% | 0.97% |
| ROE (TTM) | -1.01% | 0.95% |
| Net Profit Margin (TTM) | -1.76% | -1.88% |
| ROIC 5YR AVG | 4.80% | 4.28% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.72% | 242.78% | 71.28% |
| Revenue | 4.23% | 31.08% | 27.95% |
| Net Income | 73.49% | 330.39% | 122.33% |
| Cash Flow | 46.96% | 43.57% | 269.95% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.06 | 5.79 |
| Quick Ratio (TTM) | 0.96 | 4.98 |
| D/E Ratio (TTM) | 0.15 | 0.14 |
| Interest Coverage (TTM) | 5.15 | 30.50 |
| Piotroski F-Score | 4 | 4 |
| Altman Z-Score | 2.13 | 8.18 |
| LTL to 5YR AVG FCF | 11.17 | 6.38 |
| Shares Outstanding Growth 5YR AVG | 18.20% | 13.96% |